Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence.

Onco Targets Ther · 2014 · PMC4037327 · PMID 24876784

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

33 This trial also demonstrated a PFS benefit with a trend toward OS that did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.